Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
Clinical trial NCT03666221 · UNKNOWN
Trial details
- NCT number
- NCT03666221
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2020-04-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.